Yiyi Yan

14PUBLICATIONS
110CO-AUTHORS
Predictive and prognostic markersAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 15, 2026
Circumscribed Meningeal Melanocytic Neoplasms: CNS WHO Grade, Molecular Profile, and Clinical Outcomes.

|Apr 01, 2026
Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies.

Xingxing Zhu, Yue Yu, Shiju Chen

|Mar 11, 2026
Engineering T Cells with a Tumor-Reactive Chimeric T-cell Receptor Reduces Exhaustion and Promotes Persistence to Elicit Enhanced Antitumor Responses.

Joey C Magno, Jitao Guo, Spencer C Hall

|Apr 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial.

Matthew S Block, Garth D Nelson, Jun Chen

|Mar 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial.

Jacob J Orme, Henan Zhang, Prashanth Lingamaneni

|Jan 27, 2025
Towards H&E Referenced Multiplex Immunofluorescence Interpretation: Spatial Co-localization, Cell Feature Validation, and Virtual H&E Generation.

Chen Wang, Jun Jiang, Raymond Moore

Pageof 3

Frequent Collaborators

4 joint publications

Haidong Dong

3 joint publications

Matthew S Block

3 joint publications

Robert R McWilliams

3 joint publications

Aaron S Mansfield